Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Heidi Erickson
Manager, Pulmonary Research
Medicine
Full Page
Overview
Research
More
Collaboration
(33)
Sairam Parthasarathy
Mutual work: 6 Grants﹒1 Supervisor﹒6 Proposals
Collaboration Details
Kenneth Knox
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Denise Roe
Mutual work: 2 Proposals
Collaboration Details
Bonnie LaFleur
Mutual work: 1 Proposal
Collaboration Details
Jarrod Mosier
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Page 1 of 7
Previous page
Next page
Grants
(17)
RECOVER-SLEEP: A Platform Protocol for Evaluation of Interventions for Sleep Disturbances in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Active
·
2024
·
$0 / $359.6K
·
External
sleep disturbances,
interventions,
sars-cov-2,
evaluation,
platform protocol
RECOVER-ENERGIZE: A Platform Protocol for Evaluation of Interventions for Exercise Intolerance in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Active
·
2024
·
$0 / $167.9K
·
External
exercise,
sars-cov-2,
interventions,
evaluation
RECOVER-ENERGIZE: A Platform Protocol for Evaluation of Interventions for Exercise Intolerance in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Active
·
2024
·
$0 / $167.9K
·
External
sars-cov-2,
interventions,
post-acute sequelae,
evaluation protocol
RECOVER-VITAL: A Platform Protocol for Evaluation of Interventions for Viral Persistence, Viral Reactivation, and Immune Dysregulation in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Active
·
2023
·
$0 / $1.8M
·
External
viral persistence,
immune dysregulation,
intervention evaluation,
post-acute sequelae,
viral reactivation
RECOVER-VITAL: A Platform Protocol for Evaluation of Interventions for Viral Persistence, Viral Reactivation, and Immune Dysregulation in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Active
·
2023
·
$0 / $1.8M
·
External
viral persistence,
immune dysregulation,
interventions evaluation,
sars-cov-2,
post-acute sequelae
Page 1 of 4
Previous page
Next page
